FINWIRES · TerminalLIVE
FINWIRES

加拿大皇家银行表示，尽管面临可持续发展方面的质疑，瑞银集团的核心“优势”在第一季度依然闪耀。

By

-- 瑞银集团（UBS）第一季度业绩凸显了其核心业务模式的“实力”，并增强了股东对未来回报的信心。不过，加拿大皇家银行资本市场（RBC Capital Markets）周四发布的报告指出，尽管本季度的趋势可能并非完全可持续，但瑞银集团的业绩依然强劲。 报告称，强劲的营收增长、严格的成本控制和稳健的资本积累为瑞银未来的资本分配和股票回购提供了更大的“灵活性”。报告还指出，瑞银本季度的内生资本积累达到30个基点，有助于抵消“监管方面的不利因素”，并为2026年的潜在分红提供支持。 报告还提到，监管压力在“条例变更”幅度低于预期后略有缓解，预计这将带来70亿美元的收益（与之前的预期相比）。然而，加拿大皇家银行表示，与“外国子公司资本化”相关的拟议规则仍然“与预期一样严苛”，并可能造成资本效率低下。 报告称，瑞银财富管理业务在美洲和亚太地区呈现强劲增长势头，这得益于客户活跃度、存款和贷款增长以及盈利能力的提升。 加拿大皇家银行维持对瑞银的“跑赢大盘”评级，并将目标股价从37瑞士法郎上调至38瑞士法郎（48.75美元）。

Price: $44.46, Change: $-0.75, Percent Change: -1.66%

Related Articles

Insider Trading

Teva Pharmaceutical Industries Insider Sold Shares Worth $384,444, According to a Recent SEC Filing

Amir Weiss, Chief Accounting Officer, on May 06, 2026, sold 10,679 shares in Teva Pharmaceutical Industries (TEVA) for $384,444. Following the Form 4 filing with the SEC, Weiss has control over a total of 20,016 ordinary shares of the company, with 20,016 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/818686/000119312526211855/xslF345X05/ownership.xml

$TEVA
Research

Research Alert: CFRA Maintains Buy Opinion On Shares Of Doordash, Inc.

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lift our price target by $2 to $240, based on 30x our 2027 EPS view, just below DASH's three-year average (~32x) given competitive threats from AI and Uber Eats, offset by the company's dominant market position and positive network effects. We raise our 2026 adjusted EPS view by $0.10 to $5.63 and 2027's by $0.06 to $7.99. We are encouraged by DASH's Q2 Marketplace GOV guidance (+36% Y/Y), an encouraging result following relatively soft guidance for Q1, especially given fears of a weakening consumer. International sales continue to scale solidly, with Deliveroo accelerating to 14% Y/Y growth in Q1 vs. 7% growth in Q4 (we expect continued improvement all year). Margin pressure remains (adjusted EBITDA margin -20 bps Y/Y to 2.4%) but should fade as platform integration activities finish up early next year. Adjusted EBITDA guidance (midpoint of $820M) was above expectations ($742M), despite the company expecting another $50M gas relief charge, which should persist amid the Strait of Hormuz closure.

$DASH
Research

Research Alert: CFRA Keeps Buy Opinion On Shares Of Tyson Foods, Inc.

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:Our 12-month target remains $76, a 15x multiple of projected FY 27 EPS of $5.09 (raised by $0.02). We also lift our FY 26 (Sep.) EPS est. by $0.09 to $4.11. This multiple is slightly above TSN's long-term average of 14x, reflecting favorable secular tailwinds, including a continued shift in consumer preferences toward protein and improved earnings growth potential as the Beef segment recovers, likely in FY 27. Operationally, TSN is executing well, particularly in Chicken, where margins continue to widen, up 290 bps year over year in FQ2. Beef remains pressured by historically tight cattle supplies, with the U.S. herd at its lowest level since 1951, though we expect margins to improve following recent restructuring actions, including rightsizing production to improve capacity utilization. TSN's balance sheet is solid, noting its leverage ratio (net debt/adjusted EBITDA) has now improved to 2.2x vs. 3.9x two years ago. This provides a decent degree of financial flexibility in our view.

$TSN